Kang Choon Lee
SungKyunKwan University, South Korea
Dr. Kang Choon Lee is Haengdan Distinguished Professor at College of Pharmacy, SungKyunKwan University, Korea. For over 35 years, Dr. Lee’s Drug Targeting Laboratory has been focused on immuno-targeting and bioconjugation of peptide and protein drugs. Dr. Lee is internationally recognized as one of the leading experts in site-specific peptide/protein PEGylation and firstly demonstrated the therapeutic potential of novel site-specific PEGylated drugs such as GLP-1 and TRAIL. He has published over 150 papers in peer-reviewed journals and served as an invited speaker at many international conferences. Dr. Lee is an inventor on more than 20 patents related to specific bioconjugation and PEGylation of peptide/protein drugs. Dr. Lee is honored as a Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2003. He currently serves on the editorial advisory board of many international scientific journals. For the clinically translating and commercializing site-specific engineered peptide/protein drugs developed by his laboratory, he founded D&D PharmaTech, Korea and also co-founded and serves as a Board Member of Theraly Pharmaceuticals, USA.